Maximus, Inc. (NYSE:MMS) Stake Increased by Raymond James & Associates

Raymond James & Associates increased its stake in Maximus, Inc. (NYSE:MMSGet Rating) by 19.7% in the third quarter, Holdings Channel reports. The institutional investor owned 29,330 shares of the health services provider’s stock after acquiring an additional 4,833 shares during the quarter. Raymond James & Associates’ holdings in Maximus were worth $1,697,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. lifted its holdings in Maximus by 1.1% in the first quarter. BlackRock Inc. now owns 7,014,024 shares of the health services provider’s stock worth $525,701,000 after acquiring an additional 74,106 shares during the last quarter. Victory Capital Management Inc. grew its position in Maximus by 7.8% in the second quarter. Victory Capital Management Inc. now owns 5,672,770 shares of the health services provider’s stock worth $354,604,000 after buying an additional 408,672 shares during the last quarter. FMR LLC grew its position in Maximus by 3.0% in the second quarter. FMR LLC now owns 2,973,346 shares of the health services provider’s stock worth $185,863,000 after buying an additional 86,604 shares during the last quarter. State Street Corp grew its position in Maximus by 2.3% in the second quarter. State Street Corp now owns 2,587,930 shares of the health services provider’s stock worth $161,772,000 after buying an additional 57,997 shares during the last quarter. Finally, Mondrian Investment Partners LTD grew its position in Maximus by 1.9% during the 3rd quarter. Mondrian Investment Partners LTD now owns 1,173,933 shares of the health services provider’s stock worth $67,936,000 after purchasing an additional 21,343 shares in the last quarter. Institutional investors own 97.41% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on MMS. StockNews.com began coverage on shares of Maximus in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. TheStreet upgraded shares of Maximus from a “c+” rating to a “b-” rating in a report on Thursday, December 8th.

Maximus Trading Down 1.1 %

Maximus stock opened at $71.79 on Wednesday. The company’s fifty day simple moving average is $71.32 and its 200-day simple moving average is $64.68. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.83. Maximus, Inc. has a 12 month low of $54.46 and a 12 month high of $79.78. The stock has a market cap of $4.36 billion, a P/E ratio of 21.82 and a beta of 0.70.

Maximus (NYSE:MMSGet Rating) last posted its quarterly earnings results on Monday, November 21st. The health services provider reported $1.40 EPS for the quarter, beating the consensus estimate of $1.02 by $0.38. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.09 billion. Maximus had a net margin of 4.40% and a return on equity of 17.59%. As a group, sell-side analysts forecast that Maximus, Inc. will post 3.87 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 28th. Stockholders of record on Wednesday, February 15th will be issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date of this dividend is Tuesday, February 14th. Maximus’s dividend payout ratio is 34.04%.

Insider Activity

In related news, Director Raymond B. Ruddy acquired 5,730 shares of the stock in a transaction dated Wednesday, December 7th. The shares were acquired at an average price of $69.91 per share, with a total value of $400,584.30. Following the acquisition, the director now owns 109,030 shares in the company, valued at approximately $7,622,287.30. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Raymond B. Ruddy acquired 5,730 shares of the stock in a transaction dated Wednesday, December 7th. The shares were acquired at an average price of $69.91 per share, with a total value of $400,584.30. Following the acquisition, the director now owns 109,030 shares in the company, valued at approximately $7,622,287.30. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel David Francis sold 1,800 shares of the firm’s stock in a transaction that occurred on Wednesday, November 23rd. The shares were sold at an average price of $70.92, for a total value of $127,656.00. Following the completion of the sale, the general counsel now directly owns 13,658 shares in the company, valued at approximately $968,625.36. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Maximus Company Profile

(Get Rating)

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.

See Also

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSGet Rating).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.